Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

portal hypertension

  • Open Access
    Transjugular Liver Biopsy for Histological Diagnosis of Refractory Ascites and Evaluation of Portal Hypertension
    TORU ISHIKAWA, RYO SATO, HIROKI NATSUI, TAKAHIRO IWASAWA, MASAHIRO OGAWA, YUJI KOBAYASHI, TOSHIFUMI SATO, JUNJI YOKOYAMA and TERASU HONMA
    In Vivo May 2025, 39 (3) 1591-1597; DOI: https://doi.org/10.21873/invivo.13959
  • Open Access
    Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma
    TORU ISHIKAWA, NANAKO TERAI, RYO SATO, HIROKI NATSUI, TAKAHIRO IWASAWA, MASAHIRO OGAWA, YUJI KOBAYASHI, TOSHIFUMI SATO, JUNJI YOKOYAMA, AKIHIKO IIDUKA and TERASU HONMA
    In Vivo March 2025, 39 (2) 936-941; DOI: https://doi.org/10.21873/invivo.13898
  • Open Access
    Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma
    TORU ISHIKAWA, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA
    In Vivo September 2024, 38 (5) 2501-2505; DOI: https://doi.org/10.21873/invivo.13721
In Vivo

© 2026 In Vivo

Powered by HighWire